Equities research analysts at StockNews.com started coverage on shares of SenesTech (NASDAQ:SNES – Get Free Report) in a research report issued to clients and investors on Sunday. The brokerage set a “sell” rating on the stock.
Separately, HC Wainwright increased their price target on SenesTech from $3.50 to $10.00 and gave the company a “buy” rating in a report on Thursday, December 12th.
Check Out Our Latest Stock Report on SNES
SenesTech Stock Up 4.5 %
SenesTech Company Profile
SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.
Read More
- Five stocks we like better than SenesTech
- How to invest in marijuana stocks in 7 steps
- These 4 Tech ETFs Just Hit 50-Day Lows—Time to Buy?
- Ride Out The Recession With These Dividend Kings
- 3 Stocks to Buy While Others Stay on the Sidelines
- 5 Top Rated Dividend Stocks to Consider
- MarketBeat Week in Review – 03/03 – 03/07
Receive News & Ratings for SenesTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SenesTech and related companies with MarketBeat.com's FREE daily email newsletter.